Pralsetinib | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Pralsetinib
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Pralsetinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 2 USDMF, 3 NDC API, 1 Listed Suppliers, $ API Reference Price

3 API Suppliers
2 USDMF
3 NDC API
1 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

2 FDF Dossiers
2 FDA Orange Book

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 33 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
33 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

5 US Patents, 4 US Exclusivities

5 US Patents
4 US Exclusivities

$ API Ref.Price (USD/KG) : 184,370 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 5RIGEL PHARMS

filter Patent Number Reset all filters

5 All

01 210030005

02 111273160

03 111872192

04 111963958

filter API Patent Reset all filters

5 All

01 2Y

02 3Blank

filter FDF Patent Reset all filters

5 All

01 2Y

02 3Blank

filter Expiration Date Reset all filters

5 All

01 22036-11-01

02 32039-04-03

Product Main Page

01

RIGEL PHARMS

PharmScience R&D

Not Confirmed

RIGEL PHARMS

Country

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-11-01

PRALSETINIB

US Patent Number : 10030005

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213721

Patent Use Code : U-2952

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-11-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

RIGEL PHARMS

PharmScience R&D

Not Confirmed

RIGEL PHARMS

Country

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-11-01

PRALSETINIB

US Patent Number : 10030005

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213721

Patent Use Code : U-3002

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-11-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

RIGEL PHARMS

PharmScience R&D

Not Confirmed

RIGEL PHARMS

Country

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-04-03

PRALSETINIB

US Patent Number : 11273160

Drug Substance Claim :

Drug Product Claim :

Application Number : 213721

Patent Use Code : U-2952

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-04-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

RIGEL PHARMS

PharmScience R&D

Not Confirmed

RIGEL PHARMS

Country

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-04-03

PRALSETINIB

US Patent Number : 11872192

Drug Substance Claim :

Drug Product Claim :

Application Number : 213721

Patent Use Code : U-2952

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-04-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

RIGEL PHARMS

PharmScience R&D

Not Confirmed

RIGEL PHARMS

Country

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-04-03

PRALSETINIB

US Patent Number : 11963958

Drug Substance Claim :

Drug Product Claim :

Application Number : 213721

Patent Use Code : U-2828

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-04-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!